Abstract:Colitis is considered a significant risk factor for the development and progression of colorectal cancer due to excessive inflammation formed as a result of inflammatory bowel disease (IBD), which is linked to colorectal cancer development. Colorectal cancer often lacks overt symptoms in its early stages, leading to late-stage diagnosis in most patients. Therefore, timely diagnosis and differentiation of colitis and colorectal cancer are crucial. This study introduces a novel activatable carboxylesterase 2 (CES2) fluorescent probe, DBF-CES2, consisting of a cationic indolium fluorophore and a CES2-specific benzyl ester recognition group. The probe operates via the intramolecular charge transfer (ICT) mechanism. Upon binding and hydrolysis by CES2, a potent electron-donating hydroxyl group is released, enhancing the ICT effect and increasing fluorescence intensity, emitting red fluorescence light (λem = 680nm). The probe had a large Stokes shift of 167nm and a detection limit as low as 0.70ng/mL. It also had high selectivity, sensitivity, and biocompatibility. Cellular imaging experiments demonstrated that CES2 expression levels in colorectal cancer cells were higher than those in normal cells. The DBF-CES2 probe specifically recognized endogenous CES2 in colorectal cancer cells, promptly distinguishing them from normal cells. In vivo imaging in mice confirmed that the probe could differentiate between colitis and colorectal cancer, allowing for the assessment of the therapeutic effects of two drugs. The synthesized CES2-targeting organic small molecule fluorescent probe DBF-CES2 is a new molecular tool for the early diagnosis of colitis and colorectal cancer-related diseases, holding significant potential in clinical diagnostics.

Near-infrared Fluorescent Probe for Fast Track of Cyclooxygenase-2 in Golgi Apparatus in Cancer Cells

Celecoxib Conjugated Fluorescent Probe for Identification and Discrimination of Cyclooxygenase-2 Enzyme in Cancer Cells.

A Novel Near-Infrared Fluorescent Probe for Monitoring Cyclooxygenase-2 in Inflammation and Tumor

An Off-On Cox-2-Specific Fluorescent Probe: Targeting the Golgi Apparatus of Cancer Cells

Precise Detection and Visualization of Cyclooxygenase-2 for Golgi Imaging by a Light-Up Aggregation-Induced Emission-Based Probe

A Nile Blue Based Infrared Fluorescent Probe: Imaging Tumors That Over-Express Cyclooxygenase-2.

Highly Sensitive Naphthalene-Based Two-Photon Fluorescent Probe for in Situ Real-Time Bioimaging of Ultratrace Cyclooxygenase-2 in Living Biosystems.

Sensing and Imaging Agents for Cyclooxygenase Enzyme

Fluorescence Discrimination of Cancer from Inflammation by Molecular Response to COX-2 Enzymes

Hybrid fluorescent conjugates of COX-2 inhibitors: search for a COX-2 isozyme imaging cancer biomarker.

Discovery of a Redox-Activatable Chemical Probe for Detection of Cyclooxygenase-2 in Cells and Animals

One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging

Development of Rofecoxib-Based Fluorescent Probes and Investigations on Their Solvatochromism, AIE Activity, Mechanochromism, and COX-2-Targeted Bioimaging.

A Hypoxia-Activated Near Infrared Fluorescent Probe for Cyclooxygenase-2 and in Vivo Imaging for Tumor and Inflammation

A Near-Infrared Fluorescence Probe with a Large Stokes Shift for Detecting Carbon Monoxide in Living Cells and Mice

Imaging and Inhibiting Cyclooxygenase-2 Using Aspirin-Based Fluorescent Reporter for the Treatment of Breast Cancer

Near‐Infrared Fluorescent Heptamethine Cyanine Dyes for COX‐2 Targeted Photodynamic Cancer Therapy

A COX2-targeting cancer-specific fluorescent probe for hydrogen sulfide detection in living cells, Caenorhabditis elegans , and zebrafish

A Tumor-Targeting and Polarity-Specific Near-Infrared Fluorescent Probe for Accurate Cancer Diagnosis in Vivo

Carboxylesterase 2-Based Fluorescent Probe with Large Stokes Shift for Differentiating Colitis from Bowel Cancer

Detection of carcinogen-induced bladder cancer by fluorocoxib A